肾移植术后重症肺炎的预后及治疗

Prognosis and treatment of severe pulmonary infection after kidney transplantation

  • 摘要: 目的: 探讨肾移植术后重症肺部感染的综合治疗,并对影响预后诸因素进行分析。方法: 回顾性分析45例肾移植术后发生重症肺部感染患者的临床资料,以死亡是否发生作为因变量,治疗和预后的各项暴露因素作为自变量进行统计学分析。结果: 45例患者治愈32例,总治愈率71.1%,死亡13例(其中6例放弃治疗),总死亡率28.9%。合并巨细胞病毒感染、细菌感染、急性呼吸窘迫综合征的死亡率显著升高;感染持续时间和患者死亡率成正比;患者性别、服用免疫抑制剂种类和死亡率之间无显著相关。结论: 治疗针对预后风险度高因素采取高效价药物"降阶梯治疗";免疫抑制过度及时减量或停用免疫抑制剂,加用丙种球蛋白。

     

    Abstract: Objective: To evaluate the significance of comprehensive treatment of severe pulmonary infection in patients after kidney transplantation,and investigate the prognosis of severe pulmonary infection in patients after kidney transplantation. Methods: The clinical data of 45 patients with severe pulmonary infection following kidney transplantation were analyzed retrospectively. Results: Among 45 patients,32 patients were cured and 13 patients died.6 patients gave up therapies due to high expenses.The mortality rate of patients who were complicated with cytomegalovirus infection,bacterial infection,acute respiratory distress syndrome(ADRS) significantly increased.Duration of pulmonary infection was proportional to mortality.Sex and type of immune depressant were not significantly correlated with mortality. Conclusion: De-escalation therapy with high potency drugs has proved to be successful in treating severe pulmonary infection in patients after kidney transplantation.Immunosuppressant should be reduced or withdrawn and gamma globulin be added when excess immunologic suppression occurs.

     

/

返回文章
返回